Strides Shasun’s subsidiary - Universal Corporation, Kenya, has received the GMP status for its Kenyan facility from World Health Organization (WHO) confirming compliance with standards of Good Manufacturing Practices (GMP).
The company has initiated site transfer for its Anti-Retro Viral (ARV) portfolio to the facility and will participate in global donor funding and local government programs.
Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.
